Skip to main content

4D Molecular Therapeutics, Inc.

FDMT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001650648

In the last 90 days, 4D Molecular Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $771.2M in total; no superinvestor holds it.

13F holders, Q2 2021

Institutional positions in 4D Molecular Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
56
−8 vs. Q1 2021
Shares held
16.6M
+1.23M (+8.0%) vs. Q1 2021
Total value
$400.0M
−$264.8M (−39.8%) vs. Q1 2021
New holders
10
31 more added
Sold out
18
11 more reduced

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FDMT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 56 institutions
Q1 2021: 64 institutionsQ2 2021: 56 institutionsQ3 2021: 63 institutionsQ4 2021: 77 institutionsQ1 2022: 80 institutionsQ2 2022: 90 institutionsQ3 2022: 88 institutionsQ4 2022: 96 institutionsQ1 2023: 94 institutionsQ2 2023: 100 institutionsQ3 2023: 110 institutionsQ4 2023: 111 institutionsQ1 2024: 147 institutionsQ2 2024: 143 institutionsQ3 2024: 140 institutionsQ4 2024: 146 institutionsQ1 2025: 126 institutionsQ2 2025: 121 institutionsQ3 2025: 134 institutionsQ4 2025: 153 institutionsQ1 2026: 153 institutionsQ2 2026: 157 institutions
Value heldQ2 2021: $400.0M
Q1 2021: $664.8MQ2 2021: $400.0MQ3 2021: $515.1MQ4 2021: $541.8MQ1 2022: $395.3MQ2 2022: $181.7MQ3 2022: $210.4MQ4 2022: $621.9MQ1 2023: $522.3MQ2 2023: $745.3MQ3 2023: $533.6MQ4 2023: $859.8MQ1 2024: $1.79BQ2 2024: $1.20BQ3 2024: $629.2MQ4 2024: $260.6MQ1 2025: $139.8MQ2 2025: $149.9MQ3 2025: $343.2MQ4 2025: $400.5MQ1 2026: $471.4MQ2 2026: $771.2M
Institutions holding FDMT and their total value by quarter
QuarterHoldersValue
Q2 2026157$771.2M
Q1 2026153$471.4M
Q4 2025153$400.5M
Q3 2025134$343.2M
Q2 2025121$149.9M
Q1 2025126$139.8M
Q4 2024146$260.6M
Q3 2024140$629.2M
Q2 2024143$1.20B
Q1 2024147$1.79B
Q4 2023111$859.8M
Q3 2023110$533.6M
Q2 2023100$745.3M
Q1 202394$522.3M
Q4 202296$621.9M
Q3 202288$210.4M
Q2 202290$181.7M
Q1 202280$395.3M
Q4 202177$541.8M
Q3 202163$515.1M
Q2 202156$400.0M
Q1 202164$664.8M

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding 4D Molecular Therapeutics, Inc.; share changes are against Q1 2021.

Institutions holding FDMT in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Viking Global Investors LPSuperinvestorViking Global Investors3,937,914$94.8M0.29%00.0%Unchanged
BVF Inc2,005,862$48.3M1.81%+974,792+94.5%Added
Janus Henderson Group PLC1,539,726$37.1M0.02%+312,329+25.4%Added
Casdin Capital, LLC1,115,555$26.9M0.68%+120,201+12.1%Added
FMR LLC1,037,726$25.0M0.00%−249,845−19.4%Reduced
ArrowMark Colorado Holdings LLC1,029,897$24.8M0.19%−18,292−1.7%Reduced
Aquilo Capital Management, LLC945,382$22.8M5.92%+644,496+214.2%Added
Octagon Capital Advisors LP831,267$20.0M4.15%+452,979+119.7%Added
BlackRock Inc.731,410$17.6M0.00%+184,006+33.6%Added
Alkeon Capital Management LLC502,926$12.1M0.04%+100,000+24.8%Added
Vanguard Group Inc470,276$11.3M0.00%+33,014+7.6%Added
Morgan Stanley430,787$10.4M0.00%+158,641+58.3%Added
Perceptive Advisors LLC375,256$9.04M0.12%−69,622−15.6%Reduced
Millennium Management LLC352,051$8.48M0.01%+17,902+5.4%Added
Laurion Capital Management LP275,123$6.63M0.10%−1,171−0.4%Reduced
Geode Capital Management, LLC167,434$4.03M0.00%+21,136+14.4%Added
State Street Corp165,492$3.98M0.00%+58,659+54.9%Added
Soleus Capital Management, L.P.100,800$2.43M0.37%+14,700+17.1%Added
Northern Trust Corp98,528$2.37M0.00%+11,385+13.1%Added
Charles Schwab Investment Management Inc63,220$1.52M0.00%+5,253+9.1%Added
Eagle Health Investments LP57,090$1.38M0.47%+7,090+14.2%Added
Woodline Partners LP38,708$932.0K0.02%−47,121−54.9%Reduced
Jacobs Levy Equity Management, Inc37,417$901.0K0.01%+37,417New
Parametric Portfolio Associates LLC32,158$774.0K0.00%+685+2.2%Added
Bank of New York Mellon Corp28,636$689.0K0.00%+8,219+40.3%Added
Citadel Advisors LLC27,312$658.0K0.00%+7,696+39.2%Added
Nuveen Asset Management, LLC26,922$648.0K0.00%+9,191+51.8%Added
Swiss National Bank20,600$496.0K0.00%+20,600New
California State Teachers Retirement System13,558$326.0K0.00%+1,821+15.5%Added
JPMorgan Chase & Co13,086$316.0K0.00%−7,785−37.3%Reduced
Victory Capital Management Inc12,390$298.0K0.00%−253−2.0%Reduced
Walleye Capital LLC12,205$294.0K0.01%+12,205New
Bank of America Corp11,015$265.0K0.00%+4,138+60.2%Added
Deutsche Bank AG10,641$257.0K0.00%+930+9.6%Added
M&T Bank Corp10,495$253.0K0.00%00.0%Unchanged
Resolute Partners Group9,621$232.0K0.04%+21+0.2%Added
Rhumbline Advisers9,507$229.0K0.00%+3,651+62.3%Added
SG Americas Securities, LLC9,265$223.0K0.00%+9,265New
State of Wisconsin Investment Board8,786$212.0K0.00%+8,786New
Vident Investment Advisory, LLC8,521$205.0K0.01%+8,521New
New York State Common Retirement Fund7,761$187.0K0.00%+4,261+121.7%Added
Virtus ETF Advisers LLC7,642$184.0K0.08%+7,642New
Advisor Group Holdings, Inc.5,875$141.0K0.00%+5,875New
American International Group, Inc.5,504$133.0K0.00%+969+21.4%Added
Federated Hermes, Inc.4,200$101.0K0.00%−145,800−97.2%Reduced
Citigroup Inc1,585$38.0K0.00%+217+15.9%Added
Rockefeller Capital Management L.P.1,200$28.0K0.00%−4,735−79.8%Reduced
Tower Research Capital LLC (TRC)970$23.0K0.00%+366+60.6%Added
Wells Fargo & Company825$20.0K0.00%−1,615−66.2%Reduced
Legal & General Group Plc814$20.0K0.00%+22+2.8%Added
Royal Bank of Canada675$16.0K0.00%−38−5.3%Reduced
Ameritas Investment Partners, Inc.633$15.0K0.00%00.0%Unchanged
Evolution Wealth Advisors, LLC361$9.00K0.00%+75+26.2%Added
Signaturefd, LLC86$2.00K0.00%+86New
Newbridge Financial Services Group, Inc.30$1.00K0.00%00.0%Unchanged
US Bancorp20$00.00%+20New
SB Management Ltd0$00.00%−347,910−100.0%Sold out
Price T Rowe Associates Inc0$00.00%−279,746−100.0%Sold out
Cormorant Asset Management, LP0$00.00%−200,000−100.0%Sold out
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)0$00.00%−157,500−100.0%Sold out
Deerfield Management Company, L.P. (Series C)0$00.00%−150,000−100.0%Sold out
Ally Bridge Group (NY) LLC0$00.00%−150,000−100.0%Sold out
Wellington Management Group LLP0$00.00%−90,251−100.0%Sold out
TD Asset Management Inc0$00.00%−27,448−100.0%Sold out
UBS Group AG0$00.00%−20,592−100.0%Sold out
Acuta Capital Partners, LLC0$00.00%−20,000−100.0%Sold out
Marshall Wace, LLP0$00.00%−18,760−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−12,486−100.0%Sold out
Capstone Investment Advisors, LLC0$00.00%−5,879−100.0%Sold out
Caas Capital Management LP0$00.00%−5,000−100.0%Sold out
MetLife Investment Management0$00.00%−4,083−100.0%Sold out
Metropolitan Life Insurance Co0$00.00%−2,984−100.0%Sold out
STRS Ohio0$00.00%−1,900−100.0%Sold out
Bank of Montreal0$00.00%−244−100.0%Sold out